Metro Healthcare Indonesia Tbk. vs Citra Borneo Utama Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Citra Borneo Utama Tbk. trades at Rp795 (market cap 2.47T, 58.6K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 5.8× Citra Borneo Utama Tbk.'s market cap, and Metro Healthcare Indonesia Tbk. is more actively traded (346.3K versus 58.6K). Which is the better fit depends on your goals.
| CARE | CBUT | |
|---|---|---|
Market Cap | 14.23T | 2.47T |
Volume | 346.3K | 58.6K |
Lot | 3.46K | 586 |
Turnover | 147.93M | 46.6M |
Average Price | 427.18 | 795.15 |
Value | 147.93M | 46.6M |
Indicative Equilibrium Price | 428 | 795 |
Indicative Equilibrium Volume | 10 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →